EUVIMEDEUVIMED entdecken
Evaluationsstudie

Evaluation of the Effect of Acetyl L-Carnitine on Experimental Cisplatin Ototoxicity and Neurotoxicity

Dilek Gunes, Günay Kirkim, Efsun Kolatan, Enis Alpin Guneri, Candan Ozogul, Zekiye Altun, Bülent Serbetcioglu, Osman Yilmaz, Safiye Aktas, Kamer Mutafoglu, Ozlem Tufekci, Zübeyde Erbayraktar und 1 weitere

Chemotherapy · 2011 · 57 (3) · 186-194

DOI: 10.1159/000323621 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Chemotherapy, online erschienen am 27.04.2011. Verfasst von Dilek Gunes und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Oncology, Institute of Oncology, Dokuz Eylul University, Izmir, Turkey. dilek.gunes@deu.edu.tr. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cisplatin (CDDP) is an effective and widely used chemotherapeutic agent for pediatric tumors, and ototoxicity is one of the dose-limiting side effects.

Objective

It was the aim of our study to investigate the effect of acetyl L-carnitine (ALCAR) on experimental CDDP ototoxicity by audiologic tests, histomorphologic, immunohistochemical and ultrastructural examinations and to investigate the apoptotic pathways. Materials and Methods: Wistar albino rats (n = 28) were studied. Baseline audiological tests were performed in 4 groups: group 1, control; group 2, ALCAR; group 3, CDDP; group 4, CDDP + ALCAR-administered rats. Control audiological tests were performed on the 3rd day, and then the rats were sacrificed. Ear and brain specimens were examined by transmission electron microscopy, and caspase 3, 8 and 9 activities were investigated.

Results

The CDDP-administered rats showed significant auditory brainstem response threshold shifts using all stimuli (clicks, 6-kHz and 8-kHz tone burst) compared with the control groups. The CDDP + ALCAR-administered rats showed significant auditory brainstem response threshold shifts by only click stimuli compared with the control groups. In the brain, spiral ganglion and organ of Corti, ultrastructural damage was prominent in group 3; the number of TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling)-positive cells and caspase 3, 8 and 9 immunostaining cells was significantly high in group 3.

Conclusion

ALCAR improves CDDP-induced auditory impairment, and also antioxidative and antiapoptotic properties of ALCAR on CDDP ototoxicity were supported by the findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetylcarnitineAnimalsAntineoplastic AgentsBrainCaspase 3Caspase 8Caspase 9CisplatinEar, MiddleEvoked Potentials, Auditory, Brain StemFemaleHair Cells, AuditoryHearing DisordersOrgan of CortiRatsRats, WistarVitamin B Complex

Substanzen

Antineoplastic AgentsVitamin B ComplexAcetylcarnitineCaspase 3Caspase 8Caspase 9Cisplatin

Autor:innen und Institutionen

  • Department of Pediatric Oncology, Institute of Oncology, Dokuz Eylul University, Izmir, Turkey. dilek.gunes@deu.edu.tr

Zitieren

APA

Gunes, D., Kirkim, G., Kolatan, E., Guneri, E. A., Ozogul, C., Altun, Z., Serbetcioglu, B., Yilmaz, O., Aktas, S., Mutafoglu, K., Tufekci, O., Erbayraktar, Z., & Olgun, N. (2011). Evaluation of the Effect of Acetyl L-Carnitine on Experimental Cisplatin Ototoxicity and Neurotoxicity. Chemotherapy, 57(3), 186-194. https://doi.org/10.1159/000323621

Vancouver

Gunes D, Kirkim G, Kolatan E, Guneri EA, Ozogul C, Altun Z, et al. Evaluation of the Effect of Acetyl L-Carnitine on Experimental Cisplatin Ototoxicity and Neurotoxicity. Chemotherapy. 2011;57(3):186-194. doi:10.1159/000323621

BibTeX
@article{Gunes2011,
  author = {Gunes, Dilek and Kirkim, Günay and Kolatan, Efsun and Guneri, Enis Alpin and Ozogul, Candan and Altun, Zekiye and Serbetcioglu, Bülent and Yilmaz, Osman and Aktas, Safiye and Mutafoglu, Kamer and Tufekci, Ozlem and Erbayraktar, Zübeyde and Olgun, Nur},
  title = {Evaluation of the Effect of Acetyl L-Carnitine on Experimental Cisplatin Ototoxicity and Neurotoxicity},
  journal = {Chemotherapy},
  year = {2011},
  volume = {57},
  number = {3},
  pages = {186--194},
  doi = {10.1159/000323621}
}
Kostenlos starten →